PRIMARY STUDY

Potential of Endocannabinoids to Control Bladder Pain.

Key Findings:  Animal experiments have demonstrated that inhibition of enzymes that degrade AEA or 2-AG have the potential to prevent development of visceral and somatic pain. Local inhibition of FAAH or MAGL within the bladder may be viable options to reduce pain associated with cystitis with fewer systemic side effects, but this has not been explored.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Italy, United States

Year of Pub:  2018


Cannabinoids Studied:  Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), 2-Arachidonoyl Glycerol (2-AG), Monoacylglycerol Lipase (MAGL)

Phytocannabinoid Source:  Not Applicable

Receptors Studied:  CB1, CB2, TRPV1